Erschienen in:
01.11.2020 | Original Article
The LACE + index as a predictor of 90-day urologic surgery outcomes
verfasst von:
Gregory Glauser, Eric Winter, Ian F. Caplan, Debanjan Haldar, Stephen Goodrich, Scott D. McClintock, Thomas J. Guzzo, Neil R. Malhotra
Erschienen in:
World Journal of Urology
|
Ausgabe 11/2020
Einloggen, um Zugang zu erhalten
Abstract
Purpose
This study assessed the ability of the LACE + [Length of stay, Acuity of admission, Charlson Comorbidity Index (CCI) score, and Emergency department visits in the past 6 months] index to predict adverse outcomes after urologic surgery.
Methods
LACE + scores were retrospectively calculated for all consecutive patients (n = 9824) who received urologic surgery at one multi-center health system over 2 years (2016–2018). Coarsened exact matching was employed to sort patient data before analysis; matching criteria included duration of surgery, BMI, and race among others. Outcomes including unplanned hospital readmission, emergency room visits, and reoperation were compared for patients with different LACE + quartiles.
Results
722 patients were matched between Q1 and Q4; 1120 patients were matched between Q2 and Q4; 2550 patients were matched between Q3 and Q4. Higher LACE + score significantly predicted readmission within 90 days (90D) of discharge for Q1 vs Q4 and Q2 vs Q4. Increased LACE + score also significantly predicted 90D emergency room visits for Q1 vs Q4, Q2 vs Q4, and Q3 vs Q4. LACE + score was also significantly predictive of 90D reoperation for Q1 vs Q4. LACE + score did not predict 90D reoperation for Q2 vs Q4 or Q3 vs Q4 or 90D readmission for Q3 vs. Q4.
Conclusion
These results suggest that LACE + may be a suitable prediction model for important patient outcomes after urologic surgery.